ARTA
KERX

A.R.T. Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

A.R.T. Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-61,177
Closed -$230K – 1892
2018
Q2 		$230K Buy
+61,177
New +$298K 0.01% 1191
2017
Q2 		– Sell
-147,400
Closed -$907K – 1907
2017
Q1 		$907K Buy
+147,400
New +$808K 0.04% 591
2016
Q4 		– Sell
-34,400
Closed -$182K – 1463
2016
Q3 		$182K Sell
34,400
-36,854
-52% -$199K 0.06% 503
2016
Q2 		$471K Buy
+71,254
New +$398K 0.02% 823
2015
Q3 		– Sell
-395,913
Closed -$3.95M – 1749
2015
Q2 		$3.95M Buy
+395,913
New +$4.25M 0.13% 209
2015
Q1 		– Sell
-157,314
Closed -$2.23M – 1838
2014
Q4 		$2.23M Buy
+157,314
New +$2.44M 0.08% 360
2014
Q2 		– Sell
-259,439
Closed -$4.42M – 1658
2014
Q1 		$4.42M Buy
259,439
+171,488
+195% +$2.59M 0.23% 103
2013
Q4 		$1.14M Sell
87,951
-98,398
-53% -$1.18M 0.06% 430
2013
Q3 		$1.88M Buy
186,349
+40,451
+28% +$360K 0.1% 288
2013
Q2 		$1.09M Buy
+145,898
New +$1.14M 0.04% 601

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors's KERX Position: Q3 2018 in Review

A.R.T. Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 61,177 shares — an estimated $230K sold.

A.R.T. Advisors first reported a position in KERX in Q2 2013 and held it in 10 quarters. The position peaked at $4.42M in Q1 2014. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.

  • A.R.T. Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 61,177 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $230K.
  • A.R.T. Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
  • A.R.T. Advisors's Keryx Biopharmaceuticals Inc position peaked at $4.42M in Q1 2014.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.

Based on A.R.T. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.